BIO Appoints John Crowley as New CEO, Recognized Leader and Patient Advocate in Biotech Industry

The Biotechnology Innovation Organization (BIO) announces John F. Crowley as the new CEO, a long-standing leader and advocate in biotech. Crowley, a BIO Board member for over a decade, brings a wealth of experience and strong relationships within the industry. As he steps into the role, he emphasizes the industry's connection to the external landscape, including policy, patient advocacy, and engagement with patients and providers.